Clinical Trials At Yale Produces New Lupus Drugs In More Than 50 Years

“Lupus has been a challenge for researchers to study. But that is changing. Hormones and environmental triggers — among the barriers,” says Rheumatologist Dr. Fotios Koumpouras at Yale School of Medicine.

Dr. Koumpouras is currently heading a total of three clinical trials. Each of the trials are now underway and are evaluating more promising medications. Koumpouras believes that Lupus is now easier to diagnose.

As most of you may already know, lupus affects about 1.5 million people in the U.S. — where women of color are at a higher risk.

Though there is no cure for lupus, patients like Angela Ryals look forward to the cutting-edge care that medical science is determined to develop for us all.

Read the original article online as well as view the video at News8.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s